MiRank: A bioinformatics tool for gene/miRNA ranking and pathway profiling with TCGA-KEGG data sets

The Cancer Genome Atlas (TCGA) is a valuable resource for researchers, providing clinicopathological data and genomic characterizations of various carcinomas. This includes expression microarrays for genes and microRNAs, which are short RNA strands that regulate gene expression through RNA interference. Additionally, TCGA offers fields such as days_to_death and days_to_last_followup for each tumor sample. In this study, authors Siddharth G. Reddy, Weimin Xiao, and Preethi H. Gunaratne aimed to develop a software tool called MiRank that screens TCGA data sets to identify genes and miRNAs with functional involvement in specific cancers. The computational pipeline they created generates visualizations that place the screened outputs in a pathway-centric context. The screening process involves ranking genes/miRNAs based on the correlation of their expression misregulation with differential patient survival. Genes or miRNAs consistently misregulated in patients with poor survival rates but expressed more normally in patients with longer survival rates are ranked highly. Conversely, those without such correlation with patient survival are ranked lower. By running the ovarian serous cystadenocarcinoma (OV) data set through their analysis pipeline, the authors identified several highly ranked pathways and functional groups of genes like VEGF, Jun, and Fos that have been implicated in the development of epithelial ovarian carcinomas. They also noted that dysfunction of the Wnt signaling pathway has a significant impact on the survival of ovarian cancer patients. Overall, MiRank provides a comprehensive approach to identifying key genes and miRNAs involved in cancer progression by analyzing TCGA data sets and placing them within relevant biological pathways for further investigation.

The Cancer Genome Atlas (TCGA): A Valuable Resource for Cancer Research

The Cancer Genome Atlas (TCGA) is a groundbreaking project that has revolutionized cancer research. It was launched in 2005 by the National Institutes of Health (NIH) with the goal of accelerating our understanding of the molecular basis of cancer through comprehensive genomic analysis. TCGA provides researchers with access to large-scale, high-quality data sets from various types of cancers, including clinicopathological data and genomic characterizations. One such tool developed using TCGA data is MiRank, which helps identify key genes and microRNAs involved in specific cancers.

What is TCGA?

TCGA is a collaborative effort between the NIH's National Cancer Institute (NCI) and National Human Genome Research Institute (NHGRI). Its primary objective is to catalog genetic mutations responsible for different types of cancer and understand how these mutations contribute to tumor growth and progression. The project involves collecting tissue samples from thousands of patients with different types of cancer, sequencing their genomes, and analyzing the data to identify patterns that may lead to new treatments or diagnostic tools.

MiRank: A Powerful Tool for Analyzing TCGA Data

This computational pipeline generates visualizations that place the screened outputs in a pathway-centric context.

The screening process used by MiRank involves ranking genes/miRNAs based on their correlation with patient survival rates. Genes or miRNAs consistently misregulated in patients with poor survival rates but expressed more normally in patients with longer survival rates are ranked highly. Conversely, those without such correlation with patient survival are ranked lower.

Identifying Key Genes and Pathways in Ovarian Cancer

To demonstrate the effectiveness of MiRank, the authors ran the ovarian serous cystadenocarcinoma (OV) data set through their analysis pipeline. They identified several highly ranked pathways and functional groups of genes that have been implicated in the development of epithelial ovarian carcinomas. These included VEGF, Jun, and Fos – all known to play a role in cancer progression.

Furthermore, the study revealed that dysfunction of the Wnt signaling pathway has a significant impact on the survival of ovarian cancer patients. This finding highlights the potential for targeted therapies aimed at this pathway to improve patient outcomes.

The Importance of Placing Data within Biological Contexts

One key advantage of using MiRank is its ability to place TCGA data within relevant biological pathways. This approach provides researchers with a more comprehensive understanding of how different genes and miRNAs may be involved in cancer progression. It also allows for further investigation into specific pathways or functional groups that may hold promise for developing new treatments or diagnostic tools.

In Conclusion

The Cancer Genome Atlas (TCGA) has revolutionized cancer research by providing access to large-scale, high-quality data sets from various types of cancers. The recently developed software tool MiRank offers a powerful way to analyze TCGA data sets and identify key genes and miRNAs involved in specific cancers. By placing these findings within relevant biological contexts, MiRank provides researchers with a comprehensive approach to understanding cancer progression and identifying potential targets for treatment or diagnosis. As TCGA continues to expand its database, tools like MiRank will become even more valuable resources for advancing our knowledge about cancer biology.